WORCESTER, Mass. and MUMBAI, India, Nov. 25, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd. (www.shreya.co.in), the Company's importation, marketing and distribution licensee in India, today announced the successful completion of a half dozen press conferences in major Indian commercial centers in respect of the commercial launch of sales of Generex Oral-lyn, the Company's proprietary oral insulin spray product. Each press conference was well attended and the launch received extensive coverage in local media including:
